AU2003270659A8 - Aerosolized capreomycin for inhibition of pulmonary tuberculosis - Google Patents

Aerosolized capreomycin for inhibition of pulmonary tuberculosis

Info

Publication number
AU2003270659A8
AU2003270659A8 AU2003270659A AU2003270659A AU2003270659A8 AU 2003270659 A8 AU2003270659 A8 AU 2003270659A8 AU 2003270659 A AU2003270659 A AU 2003270659A AU 2003270659 A AU2003270659 A AU 2003270659A AU 2003270659 A8 AU2003270659 A8 AU 2003270659A8
Authority
AU
Australia
Prior art keywords
capreomycin
aerosolized
inhibition
pulmonary tuberculosis
tuberculosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003270659A
Other versions
AU2003270659A1 (en
Inventor
Bernardan T Doan
Carl N Kraus
Clifton E Barry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Publication of AU2003270659A8 publication Critical patent/AU2003270659A8/en
Publication of AU2003270659A1 publication Critical patent/AU2003270659A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2003270659A 2002-09-12 2003-09-12 Aerosolized capreomycin for inhibition of pulmonary tuberculosis Abandoned AU2003270659A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US41060102P 2002-09-12 2002-09-12
US60/410,601 2002-09-12
US49789203P 2003-08-25 2003-08-25
US60/497,892 2003-08-25
PCT/US2003/028889 WO2004024213A2 (en) 2002-09-12 2003-09-12 Aerosolized capreomycin for inhibition of pulmonary tuberculosis

Publications (2)

Publication Number Publication Date
AU2003270659A8 true AU2003270659A8 (en) 2004-04-30
AU2003270659A1 AU2003270659A1 (en) 2004-04-30

Family

ID=31997969

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003270659A Abandoned AU2003270659A1 (en) 2002-09-12 2003-09-12 Aerosolized capreomycin for inhibition of pulmonary tuberculosis

Country Status (2)

Country Link
AU (1) AU2003270659A1 (en)
WO (1) WO2004024213A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0517374A (en) * 2004-10-29 2008-10-07 Harvard College formulation for treatment or prevention of respiratory infection, method for treatment
EP1984741A2 (en) * 2006-01-19 2008-10-29 Mycobics B.V. i.o. Antibiotics and methods for producing them.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6316433B1 (en) * 1998-12-18 2001-11-13 Kaneka Corporation Method for treatment of bacterial infections with once or twice-weekly administered rifalazil

Also Published As

Publication number Publication date
WO2004024213A3 (en) 2004-06-03
WO2004024213A2 (en) 2004-03-25
AU2003270659A1 (en) 2004-04-30

Similar Documents

Publication Publication Date Title
IL181466A0 (en) Pulmonary delivery of inhibitors of phosphodiesterase type 5
AU2003261434A8 (en) Iminothiazolidinones as inhibitors of hcv replication
ZA200501913B (en) New compounds for the inhibition of rotamases and use thereof
HK1077762A1 (en) INHIBITORS OF TFGβ
HK1080069A1 (en) Nitrooxyderivatives of cyclooxygenase-2 inhibitors
GB2432159B (en) Intermediates for manufacturing peripherally-selective inhibitors of dopamine-beta-hydroxylase
PL369292A1 (en) Adhesion inhibition of fungi
AU2003209321A1 (en) Substituted pyridazinones as inhibitors of p38
IL180738A0 (en) Inhibitors of hcv replication
EG25482A (en) Inhibitors
IS7717A (en) Pyridazinone derivatives as PDF4 inhibitors
HK1079200A1 (en) 2-Pyridone derivatives as inhibitors of neutrophile elastase
ZA200606747B (en) New compounds for the inhibition of angiogenesis and use thereof
AU2002305205A1 (en) 9-deazaguanine derivatives as inhibitors of gsk-3
IL185768A0 (en) New salt and polymorphs of the dpp-iv inhibitor
EP1757297A4 (en) Composition for inhibiting the onset of arteriosclerosis and inhibition method
PT1403265E (en) Industrial process for the synthesis of 5-¬bis(carboxymethyl)amino -3-carboxymethyl-4-cyano-2-thiophene-carboxylic acid tetraesters and use for the synthesis of ranetic acid divalent salts and hydrates thereof
HK1080911A1 (en) Rust inhibitor
AU2003237863A1 (en) Aerosol drug inhibition of lung metastases
PL362367A1 (en) New method of industrial synthesis of methyl diester of 5-amino-3-karboxymethyl-4-cy ano-2-tiophenokarboxylic acid, method of synthesis of ranelic acid, salts of divalent metals of ranelic acid and its hydrates also new intermediate compounds
HK1081950A1 (en) 1-Oxa-dibenzoazolenes as inhibitors of thmour necrosis factor production and intermediates for the preparation thereof
AU2003270659A8 (en) Aerosolized capreomycin for inhibition of pulmonary tuberculosis
AU2003295638A8 (en) Novel inhibitors of beta-lactamase
AU2003239025A1 (en) Combination of an acid secretion inhibiting agent and a reflux inhibitor for the treatment of gerd
AU2003253678A8 (en) Identification of inhibitors of mitosis

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase